GlobeNewswire Inc.··Researchandmarkets.ComAlpha Thalassemia Market Set for Robust Growth Through 2036 on Gene Therapy Advances
Alpha thalassemia market poised for significant expansion driven by rising prevalence, diagnostic advances, and pipeline therapies from $AGIOS and $NVO through 2036.
BMYCELGrNVOAGIOclinical trialsgene therapy